Journal profile · TOXICOLOGY
Toxicon-X
ISSN 2590-1710 · Elsevier
Toxicon-X: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.2 (journal website); fully open access; APC about USD 2,580; median 69 days to acceptance (35 articles, last 24 months); 18 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Toxicon-X is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venomous Animal Envenomation and Studies, Rabies epidemiology and control and Marine Invertebrate Physiology and Ecology, together about 58.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Toxicon is affiliated with The Brazilian Society of Toxinology, The International Society on Toxinology and The North American Society of Toxinology.Toxicon is dedicated to all areas related to natural toxins and publishes peer-reviewed manuscripts describing novel findings of broad interest and importance to the toxinology community.Articles that further the understanding and knowledge of toxinology are particularly welcomed, as are review articles on toxinology. Submissions on Toxinology, Pharmacology, Immunology, Biochemistry, Health, Genetics and Molecular Biology are particularly welcomed.The journal publishes articles on the following topics:original research on toxins derived from animals, plants or microorganismsnovel findings related to the chemical, pharmacological, toxicological or immunological properties of natural toxinsmolecular biological studies of toxins and related genes from poisonous and venomous organisms that advance understanding of the role or function of toxinsthe use of toxins as tools in studying biological processesthe translational application of toxins, for example as pharmacological tools, drugs or insecticidesvenom and antivenom issuesclinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtainedepidemiological studies on envenoming or poisoning, provided they highlight a previously unrecognized medical problem or provide insight into the prevention or medical treatment of envenoming or poisoningproperly designed prospective community-based surveysToxicon does not accept submissions on: Retrospective surveys of hospital records, unless species identification is rigorous and the quality of hospital records high. Properly designed prospective clinical studies or community-based surveys are strongly encouraged.Articles describing activities of venoms or extracts, for example antibacterial, anticancer or analgesic activities, without any attempt to define the mechanism of action or purify the active component.Bibliometric studies, unless they include a critical evaluation of the field.Toxicon X is the open access companion title of:Toxicon. Both journals share the same aims and scope, editorial team, and rigorous peer review. The difference between the journals is the access model under which the journals will publish your work and the indexation status.
From the journal's Aims & Scope
Research area (LetPub): TOXICOLOGY
Editor-in-chief Bruno LomontePublisher website
Editorial board by country: 3 in mainland China (about 4%); most named Australia 15, Brazil 14, United States 10, United Kingdom 4, Mainland China 3 (73 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Venomous Animal Envenomation and StudiesBiochemistry, Genetics and Molecular Biology30.8%
- Rabies epidemiology and controlImmunology and Microbiology15.5%
- Marine Invertebrate Physiology and EcologyEarth and Planetary Sciences11.8%
- Healthcare and Venom ResearchMedicine7.5%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.7%
- Insect and Pesticide ResearchAgricultural and Biological Sciences4.3%
- Marine Toxins and Detection MethodsEnvironmental Science3.2%
- Biochemical and Structural CharacterizationBiochemistry, Genetics and Molecular Biology2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Toxicology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.2Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher)
- 6.3Publisher website ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 1.38LetPub ·
- h-index
- 29OpenAlex ·
- i10-index
- 91OpenAlex ·
- 2-year mean citedness
- 2.31OpenAlex ·
- Self-citation rate
- 3.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 17LetPub ·
Articles by year OpenAlex count · 204 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 11 |
| 2025 | 18 | 18 | 28 |
| 2024 | 22 | 22 | 102 |
| 2023 | 20 | 20 | 196 |
| 2022 | 37 | 37 | 556 |
| 2021 | 25 | 25 | 764 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
69 daysMedian, submission to acceptance · P25–P75 60 days – 112 days
- Acceptance to online
- median 7 days (35 articles)
- Submission to online
- median 80 days
- Sample
- 35 articles with submission and acceptance dates (44 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 29 daysPublisher website ·
- Submission to acceptance
- 86 daysPublisher website ·
- Acceptance to publication
- 11 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,580 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,740 / EUR 2,560 / GBP 2,190 / JPY 339,840 | — | — | |
| LetPub | USD 2,210 | Yes | — | |
| Publisher website | USD 2,930 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Author–date
- Highlights
- Required
- Graphical abstract
- Required
Article types accepted8, with length limits
- case reportFor case reports you are required to follow CARE guidelines and provide the CARE checklist at manuscript submission.Read the CARE guidelinesFollow the CARE chec…Length not stated
- case reportsToxicon: X publishes clinical reports on poisoning where a new therapeutic principle has been proposed or a decidedly superior clinical result has been establis…Length not stated
- correspondenceThese may be published if judged by the Editor to be of interest to the broad field of toxinology or of special significance to a smaller group of workers in a …Length not stated
- full-length research papersFull-Length Research Papers Articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms.Length not stated
- mini-reviewsMini-Reviews and proposals for mini-Reviews are welcomeLength not stated
- reviews and short reviewsArticles of interest to toxinologists which are published in journals other than Toxicon: X may be abstracted in the Reviews section of Toxicon: X.Length not stated
- short communicationShort Communications differ from full manuscripts only in that the research study does not lend itself to an extended presentation. Even though brief, the Short…abstract ≤ 75 words
- short communicationsShort Communications differ from full manuscripts only in that the research study does not lend itself to an extended presentation.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2590-1710
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Toxicon-X
What CAS zone is Toxicon-X in?
In the 2025 upgraded edition of the CAS Journal Ranking, Toxicon-X is in Zone 3 of Medicine, and in Zone 2 of the minor category Toxicology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Toxicon-X?
The journal's website gives an impact factor of 3.2; this is the journal's own figure, as LetPub lists none for it; CiteScore 6.3, h-index 29.
How long does peer review take at Toxicon-X?
Based on the dates recorded on 35 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 69 days (interquartile range 60–112 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Toxicon-X?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Author–date; Highlights: Required; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Toxicon-X based?
Of the 73 board members whose country the journal's board page names, 3 (about 4%) are in mainland China; the countries named most often are Australia (15), Brazil (14) and United States (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Toxicon-X?
According to LetPub and DOAJ records, Toxicon-X is indexed in ESCI, Scopus and DOAJ.
Is Toxicon-X open access, and what is the APC?
Toxicon-X is a fully open-access journal. APC about USD 2,580.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .